Pulmonary Ultrasound in the Diagnosis of Acute Thoracic Syndrome in Vaso-occlusive Sickle Cell Crisis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-04

Study Completion Date

2023-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ATS (acute thoracic syndrome) refers to acute pulmonary involvement in a sickle cell patient. The diagnosis is based on the association of clinical signs (fever or respiratory symptoms) with a recent pulmonary infiltrate on the chest x-ray.

The main objective of the study is to evaluate the place of the pulmonary ultrasound for the diagnosis of ATS, in comparison with frontal chest x-ray.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Use of Macrolides in Acute Chest Syndrome: A Multicenter Retrospective Study

NCT07037706

Sickle Cell Disease Acute Chest Syndrome Glucose-6-Phosphate Dehydrogenase Deficiency +2 more

COMPLETED

Ultrasound Acute Chest Syndrome Sickle Cell Disease

NCT06880679

Acute Chest Syndrome Sickle Cell Disease

RECRUITING NA

Evaluation of Non-invasive Endothelial Function in Children Sickle by Vascular Ultrasound

NCT02829580

Sickle Cell Disease

COMPLETED NA

Validation of a Predictive Score of Acute Chest Syndrome

NCT03032055

Vaso Occlusive Crisis Acute Chest Syndrome

UNKNOWN

Dense Red Blood Cells in Sickle Cell Children

NCT02887118

Sickle Cell Disease

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ATS occurs in half of the cases during hospitalization for a VOC (Vaso Occlusive crisis). The morbidity of ATS is important (respiratory insufficiency, duration of hospitalization, stays in intensive care, brain complications, pain, hypoxia, long-term sequelae, etc.) but no study has shown the benefits of curative treatments such as transfusion ( recommended at the time of diagnosis and practiced by some teams) or noninvasive ventilation (practiced by other teams). The first step before studying curative treatments is to have tools for early detection of ATS. Recent studies show non-inferiority of pulmonary ultrasonography compared to radiography and thoracic computed tomography in the diagnosis of pulmonary condensation (in adults and children). In a study performed in sickle cell adults admitted for ATS, pulmonary ultrasound was more sensitive than X-ray in detecting images of pulmonary consolidations visible on the chest CT scan.

Daswani et al have also shown the value of pulmonary ultrasound in comparison with radiography in the detection of consolidation lesions, suggestive of STA, in febrile children or young adults with sickle cell disease. They showed a good sensitivity (87%) and specificity (94%) of the pulmonary ultrasound.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sickle-Cell Disease Nos With Crisis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children with sickle cell disease

Child from 12 months to 18 years old admitted for vaso-occlusive crisis

Group Type OTHER

pulmonary ultrasound

Intervention Type DIAGNOSTIC_TEST

The subjects will have an ultrasound on admission and on day 1, 2 and 3

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pulmonary ultrasound

The subjects will have an ultrasound on admission and on day 1, 2 and 3

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: ≥12 months and \<18 years
* Has a major sickle cell disease whatever the genotype
* Admission to hospital for a febrile vaso-occlusive crisis (VOC) or not
* Evolving at home for less than 48h
* Concomitant treatment with hydroxycarbamide / hydroxyurea possible
* Signed consent
* Patients affiliated to a French social security scheme

Exclusion Criteria

* Child presenting an acute thoracic syndrome (ATS) from the outset at the admission
* Child who presented an ATS in the month preceding the inclusion
* Child in regular transfusion program or child who has received a hematopoietic stem cell transplant
* Child hospitalized at least 5 times for VOC in the year preceding inclusion (psychic problems making difficult the evaluation of the pain)
* Child who has already been included in the study during a previous VOC (each child participates in the study only once)
* VOC evolving for more than 48 hours before admission to the emergency room
* Acute splenic sequestration crisis at admission

Minimum Eligible Age

12 Months

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No